References
- Raacsh W, Schafer U, Chun J & Dominiak P. Biological significance of agmatine, an endogenous ligand at imidazoline binding sites. Br J Pharmacol. 2001; 133, 755-780.10.1038/sj.bjp.070415311454649
- Aricioglu-kartal F & Uzbay IT. Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats. Life Sci.1997; 61, 1775-1881.10.1016/S0024-3205(97)00801-19365224
- Regunathan S, Youngson C, RaascH W, Wang H & Reis DJ. Imidazoline receptors and agmatine in blood vessels: a novel system inhibiting vascular smooth muscle proliferation. J Pharmacol Exp Ther. 1996; 276, 1272-1282.8786560
- Gilad GM, Gilad VH & Rabey JM. Arginine and ornithine decarboxylation in rodent brain: coincidental changes during development and after ischemia. Neurosi Lett 1996; 216, 33-36.10.1016/0304-3940(96)12996-7
- Olmos G, Degregorio-Rocasolano N, Paz RM, Gasull T, Assumpcio BM, Trullas R, Villarroel A, Lerma J & Garcia-Sevilla JA. Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Br J Pharmacol. 1999; 127,1317-1326.1045528110.1038/sj.bjp.0702679
- Reis DJ & Regunathan S. Is agmatine a novel neurotransmitter in brain? TiPS. 2000; 21, 187-193.
- Goracke-Postle CJ, Overland AC, Riedl MS, Stone LS, Fairbanks CA. Potassium-and capsaicin-induced release of agmatine from spinal nerve terminals. J. Neurochem. 2007 Sep;102(6):1738-48.10.1111/j.1471-4159.2007.04647.x17539920
- Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, & Reis DJ. Agmatine: an endogenous clonidine-displacing substance in the brain. Science. 1994; 263:966-9.10.1126/science.79060557906055
- Tesson F, Prip-Buus C, Lemoine A, Pegorier JP, Parini A. Subcellular distribution of imidazoline-guanidinium-receptive sites in human and rabbit liver. Major localization to the mitochondrial outer membrane. J Biol Chem. 1991; 266:155-60.
- Tesson F, Prip-Buus C, Lemoine A, Pegorier JP & Parini A. Characterization of mitochondrial imidazoline-guanidinium receptive sites (IGRS) in liver. Am J Hypertens. 1995; 5, 805-825.
- Raddatz R, Parini A & Lanier SM. Localization of the imidazoline binding domain on monoamine oxidase. B Mol Pharmacol 1997; 52, 549-553.10.1124/mol.52.4.549
- Raddatz R, Savic SL, Bakthavachalam V, Lesnik J, Jasper JR, Mcgrath CR, Parini A, Lanier SM. Imidazoline-binding domains on monoamine oxidase B and subpopulations of enzyme. J Pharmacol Exp Ther 2000; 292, 1135-1145.10688633
- Head GA, & Mayorov DN. Imidazoline receptors, novel agents and therapeutic potential. Cardiovasc Hematol Agents Med Chem. 2006; 4:17-32.1652954710.2174/187152506775268758
- Raasch W, Muhle H, & Dominiak P. Modulation of MAO activity by imidazoline and guanidine derivatives. Ann N Y Acad Sci. 1999; 881:313-31.1041593210.1111/j.1749-6632.1999.tb09376.x
- Jones TZ, Giurato L, Guccione S. & Ramsay RR. Interactions of imidazoline ligands with the active site of purified monoamine oxidase A. FEBS J. 2007; 274, 1567-1575.1748020510.1111/j.1742-4658.2007.05704.x
- Holt A. & Baker GB. Metabolism of agmatine (clonidine-displacing substance) by diamine oxidase and the possible implications for studies of imidazoline receptors. Prog Brain Res. 1995; 106, 187-197.858465410.1016/S0079-6123(08)61215-7
- Su RB, Li J, Li X. & Qin BY. Down-regolation of MAO-B activity and imidazoline receptors in rat brain following chromic treatment of morphine. Acta Pharmacol. Sin. 2001; 22, 639-644.
- Ozaita A, Olmos G, Boronat MA, Lizcano JM, Unzeta M. & Garcia-Sevilla JA. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver. Br J Pharmacol. 1997; 121, 901-912.10.1038/sj.bjp.0701214
- Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54.10.1016/0003-2697(76)90527-3942051
- Weissbach H, Smith TE, Daly JW, Witkop B, & Udenfriend S. A rapid spectrophotometric assay of mono-amine oxidase based on the rate of disappearance of kynuramine. J Biol Chem. 1960; 235:1160-3.13843767
- Holt A, Palcic MM. A peroxidase-coupled continuous absorbance plate-reader assay for flavin monoamine oxidases, copper-containing amine oxidases and related enzymes. Nat Protoc. 2006; 1(5):2498-505.10.1038/nprot.2006.402
- Holt A., Sharman D.F., Baker G.B., & Palcic M.M. (1997). A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates. Anal Biochem. 244:384-92.902595610.1006/abio.1996.9911
- Tipton KF. Inhibition of monoamine oxidase by substituted hydrazines. Biochem J. 1992; 128:913-9.
- Kim H, Sablin SO, & Ramsay RR. Inhibition of monoamine oxidase A by beta-carboline derivatives. Arch Biochem Biophys. 1997; 337:137-42.10.1006/abbi.1996.97718990278
- Zomkowski AD, Hammes L, Lin J, Calixto JB, Santos AR, Rodrigues AL. Agmatine produces antidepressant-like effects in two models of depression in mice. Neuroreport. 2002; 13(4):387-91.1193014610.1097/00001756-200203250-00005
- Shopsin B. The clinical antidepressant effect of exogenous agmatine is not reversed by parachlorophenylalanine: a pilot study. Acta Neuropsychiatr. 2013; 25(2):113-8. doi: 10.1111/j.1601-5215.2012.00675.x.10.1111/j.1601-5215.2012.00675.x25287313
- Laube G, Bernstein HG. Agmatine: multifunctional arginine metabolite and magic bullet in clinical neuroscience? Biochem J. 2017; 474(15):2619-2640.10.1042/BCJ2017000728747403